Literature DB >> 11827989

Tumor immunotherapy: inching toward the finish line.

Tyler J Curiel1, David T Curiel.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11827989      PMCID： PMC150867          DOI： 10.1172/JCI15042

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  8 in total

1.  Gene therapy on trial.

Authors:  E Marshall
Journal:  Science       Date:  2000-05-12       Impact factor: 47.728

Review 2.  Progress in human tumour immunology and immunotherapy.

Authors:  S A Rosenberg
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 3.  Autologous dendritic cells for treatment of advanced cancer--an update.

Authors:  D Schadendorf; F O Nestle
Journal:  Recent Results Cancer Res       Date:  2001

Review 4.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

5.  Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors.

Authors:  Axel Heiser; Doris Coleman; Jens Dannull; Donna Yancey; Margaret A Maurice; Costas D Lallas; Philipp Dahm; Donna Niedzwiecki; Eli Gilboa; Johannes Vieweg
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

6.  Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.

Authors:  W Zou; V Machelon; A Coulomb-L'Hermin; J Borvak; F Nome; T Isaeva; S Wei; R Krzysiek; I Durand-Gasselin; A Gordon; T Pustilnik; D T Curiel; P Galanaud; F Capron; D Emilie; T J Curiel
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

7.  Cancer undefeated.

Authors:  J C Bailar; H L Gornik
Journal:  N Engl J Med       Date:  1997-05-29       Impact factor: 91.245

8.  Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

Authors:  J Banchereau; A K Palucka; M Dhodapkar; S Burkeholder; N Taquet; A Rolland; S Taquet; S Coquery; K M Wittkowski; N Bhardwaj; L Pineiro; R Steinman; J Fay
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701
  8 in total
  4 in total

1.  In situ regulation of DC subsets and T cells mediates tumor regression in mice.

Authors:  Omar A Ali; Dwaine Emerich; Glenn Dranoff; David J Mooney
Journal:  Sci Transl Med       Date:  2009-11-25       Impact factor: 17.956

2.  Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants.

Authors:  Omar A Ali; Catia Verbeke; Chris Johnson; R Warren Sands; Sarah A Lewin; Des White; Edward Doherty; Glenn Dranoff; David J Mooney
Journal:  Cancer Res       Date:  2014-01-30       Impact factor: 12.701

Review 3.  Tregs and rethinking cancer immunotherapy.

Authors:  Tyler J Curiel
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

4.  Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study.

Authors:  S Rutkowski; S De Vleeschouwer; E Kaempgen; J E A Wolff; J Kühl; P Demaerel; M Warmuth-Metz; P Flamen; F Van Calenbergh; C Plets; N Sörensen; A Opitz; S W Van Gool
Journal:  Br J Cancer       Date:  2004-11-01       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.